beta-lactams has been researched along with Acute Respiratory Distress Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adamzik, M; Asmussen, S; Karlik, J; Peters, J; Rahmel, T; Steinmann, J | 1 |
| Efimov, NW; Miroshnikov, BI; Remizov, AS; Skipskiy, IM | 1 |
| Garg, S; Marrie, TJ; Tyrrell, GJ; Vanderkooi, OG | 1 |
3 other study(ies) available for beta-lactams and Acute Respiratory Distress Syndrome
| Article | Year |
|---|---|
Moxifloxacin monotherapy versus combination therapy in patients with severe community-acquired pneumonia evoked ARDS.
Topics: Adult; Alanine Transaminase; Anti-Bacterial Agents; Aspartate Aminotransferases; beta-Lactams; Bilirubin; Community-Acquired Infections; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Intensive Care Units; Length of Stay; Male; Middle Aged; Moxifloxacin; Pneumonia, Bacterial; Respiratory Distress Syndrome; Retrospective Studies | 2017 |
[ACUTE RESPIRATORY DISTRESS SYNDROME CAUSED BY BETA-LACTAM ANTIBIOTICS].
Topics: Anti-Bacterial Agents; beta-Lactams; Follow-Up Studies; Glucocorticoids; Humans; Male; Middle Aged; Pneumonia; Prednisolone; Radiography, Thoracic; Respiratory Distress Syndrome | 2015 |
Factors predicting mortality in invasive pneumococcal disease in adults in Alberta.
Topics: Adolescent; Adult; Alberta; Anti-Bacterial Agents; beta-Lactams; Cognition Disorders; Comorbidity; Drug Therapy, Combination; Female; Humans; Lung; Macrolides; Male; Multivariate Analysis; Pneumococcal Infections; Renal Insufficiency; Respiratory Distress Syndrome; Retrospective Studies; Streptococcus pneumoniae; Treatment Outcome; Vancomycin; Young Adult | 2011 |